•
Mar 31, 2024

Oscar Health Q1 2024 Earnings Report

Oscar Health reported strong first quarter results with year-over-year improvement across all core metrics and achieved positive net income.

Key Takeaways

Oscar Health, Inc. announced its financial results for the first quarter ended March 31, 2024, with total revenue of $2.1 billion, a 46% increase year-over-year. The company reported a net income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share.

Total Revenue was $2.1 billion, up 46% year-over-year.

Medical Loss Ratio improved to 74.2%, a 210 bps improvement year-over-year.

SG&A Expense Ratio significantly improved to 18.4%, an 870 bps improvement year-over-year.

Net Income attributable to Oscar was $177.4 million, a significant improvement of $217.1 million year-over-year.

Total Revenue
$2.14B
Previous year: $1.47B
+45.7%
EPS
$0.62
Previous year: -$0.18
-444.4%
Medical Loss Ratio
74.2%
Previous year: 76.3%
-2.8%
Gross Profit
$2.14B
Previous year: $37.2M
+5662.9%
Cash and Equivalents
$2.23B
Previous year: $2.11B
+5.7%
Free Cash Flow
$628M
Total Assets
$4.42B
Previous year: $4.48B
-1.4%

Oscar Health

Oscar Health

Forward Guidance

Oscar is reaffirming its full year 2024 outlook across all metrics as provided in its financial results press release dated February 7, 2024.